Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients-Reference-Cited by-同舟云学术

Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients

Published:2020-06-05 Issue:11 Volume:60 Page:1461-1473
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Ber Justyna¹,Wiczling Paweł²^ORCID,Hołysz Marcin³,Klupczyńska Agnieszka⁴,Bartkowska‐Śniatkowska Alicja⁵,Bieda Krzysztof⁶,Smuszkiewicz Piotr⁷,Nowicka Małgorzata⁸,Żurański Łukasz⁸,Sobczyński Paweł⁸,Matysiak Jan⁴,Grześkowiak Edmund¹,Bienert Agnieszka¹

Affiliation:

1. Department of Clinical Pharmacy and Biopharmacy Poznan University of Medical Sciences Poznan Poland

2. Department of Biopharmacy and Pharmacodynamics Medical University of Gdansk Gdansk Poland

3. Department of Biochemistry and Molecular Biology Poznan University of Medical Sciences Poznan Poland

4. Department of Inorganic and Analytical Chemistry Poznan University of Medical Sciences Poznan Poland

5. Department of Pediatric Anesthesiology and Intensive Therapy Poznan University of Medical Sciences Poznan Poland

6. Anaesthesiology and Intensive Care Department Greater Poland Cancer Centre Poznan Poland

7. Department of Anesthesiology Intensive Therapy and Pain Treatment Heliodor Swiecicki Clinical Hospital Poznan University of Medical Sciences Poznan Poland

8. Anaesthetics and Critical Care Department University Hospital of Lord's Transfiguration Poznan University of Medical Sciences Poznan Poland

Funder

Polish National Science Centre

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1647

Reference45 articles.

1. United States Food and Drug Administration (FDA).FDA Approved Drug Products – Precedex Label.https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/21038lbl.pdf. Accessed February 15 2020.

2. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine

3. Influence of Cardiac Output on Dexmedetomidine Pharmacokinetics

4. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans;Karol MD;Balliere's Clin Anaesthesiol,2000

5. Comfort and patient-centred care without excessive sedation: the eCASH concept

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants;The Journal of Clinical Pharmacology;2024-03-28

2. Genetic polymorphisms are associated with individual susceptibility to dexmedetomidine;Frontiers in Genetics;2023-08-24

3. Population pharmacokinetic-pharmacodynamic model of dexmedetomidine in elderly patients undergoing sedation after abdominal aortic surgery;Journal of Medical Science;2023-02-20

4. A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-04-20

5. Population pharmacokinetic analysis of dexmedetomidine in children using real‐world data from electronic health records and remnant specimens;British Journal of Clinical Pharmacology;2022-01-28